Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Q2 FY27 Results: Net Profit ₹12.7 Cr, Up 429.2% YoY

Shukra Pharmaceuticals Ltd reported revenue from operations of ₹44.2 Cr (+649.2% YoY) and net profit of ₹12.7 Cr (+429.2% YoY) for Q2 FY27.

Key figure

Net profit ₹12.7 Cr · +429.2% YoY

Shukra Pharmaceuticals Q1 FY27 Results: Net Profit ₹13 Cr, Up 1200.0% YoY

Shukra Pharmaceuticals Ltd reported revenue from operations of ₹23.5 Cr (+335.2% YoY) and net profit of ₹13 Cr (+1200.0% YoY) for Q1 FY27.

Key figure

Net profit ₹13 Cr · +1200.0% YoY

Shukra Pharmaceuticals Q4 FY26 Results: Net Loss of ₹1.7 Cr

Shukra Pharmaceuticals Ltd reported revenue from operations of ₹6.3 Cr (-52.6% YoY) and a net loss of ₹1.7 Cr for Q4 FY26.

Key figure

Net loss ₹1.7 Cr

Shukra Pharmaceuticals Financial Results

Shukra Pharmaceuticals approved FY26 audited financial results and recommended a 1% final dividend. The board also allotted 17.35 lakh equity shares upon warrant conversion.